NATICK, Mass. -( Dow Jones)- Boston Scientific Corp.(BSX) reported it swung to a loss in the third quarter from a year ago, hurt by charges related to the settlement agreement with Israeli stent maker Medinol Ltd.
http://c.moreover.com/click/here.pl?r407029237
http://c.moreover.com/click/here.pl?r407029237